CRP and COVID-19: A very interesting meta-analysis focused on optimal TOC use in severe and critically ill COVID-19 patients was published by Nugroho et al. [39] The authors demonstrated that TOC reduced all-cause mortality when CRP levels were ≥100 mg/L, and PaO2/FiO2 ratios were 200–300 mmHg or <200 mmHg.